Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering Vero cells to secrete human insulin.

Lorraine O'Driscoll1, Patrick Gammell, Martin Clynes

  • 1National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Ireland. Lorraine.ODriscoll@dcu.ie

In Vitro Cellular & Developmental Biology. Animal
|May 25, 2002
PubMed
Summary

Researchers engineered Vero cells to produce human insulin for Type I diabetes treatment. While cells produced insulin, they lacked glucose-responsive secretion, indicating further research is needed for effective cell therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patients.

The journal of liquid biopsy·2026
Same author

Extracellular vesicle-mediated crosstalk in bone: miR-150-5p as a mechanosensitive regulator of osteoclastogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Mechanical Cues and Lineage Commitment Govern the Angiogenic Potential of Mesenchymal Cell-Derived Extracellular Vesicles.

Advanced biology·2026
Same author

A bibliometric systematic review of extracellular vesicles in cutaneous malignant melanoma from 2005 to 2025.

Frontiers in oncology·2026
Same author

The Antagonistic Influence of Phytic Acid on Zinc Absorption: An <i>In Vitro</i> Comparison of Inorganic and Chelated Trace Mineral Sources.

Nutrients·2026
Same author

Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.

British journal of cancer·2025

Area of Science:

  • Biotechnology
  • Cell Biology
  • Endocrinology

Background:

  • Cell therapy presents a potential treatment for Type I diabetes.
  • Developing suitable cell lines for this purpose remains a challenge.

Purpose of the Study:

  • To investigate the feasibility of modifying Vero cells, a potentially human-safe cell line, for insulin production.
  • To engineer Vero cells to express and secrete human insulin, addressing the limitations of current cell therapy approaches for diabetes.

Main Methods:

  • Vero cells were stably transfected with human preproinsulin complementary deoxyribonucleic acid (cDNA).
  • Genetic modification of cDNA enhanced furin sensitivity for insulin processing.
  • Co-transfection with GLUT2 and glucokinase (GCK) was performed to investigate glucose responsiveness.

Related Experiment Videos

Main Results:

  • Engineered Vero cells expressed proinsulin, which was processed into mature insulin.
  • Transfected cells constitutively released mature insulin but did not exhibit glucose-stimulated secretion.
  • Co-expression of GLUT2 and GCK did not restore glucose-stimulated insulin secretion; GLUT2 localized primarily to the nucleus.

Conclusions:

  • It is feasible to engineer a relatively safe non-beta cell line, such as Vero cells, to produce human insulin.
  • Achieved co-expression levels of GLUT2 and GCK are insufficient to induce glucose-stimulated insulin secretion in these engineered cells.
  • Subcellular localization of transfected components may play a critical role in functional glucose-stimulated insulin secretion.